The latest thought leadership from our expert teams

Active filters (1)
Opinion

Exploring the potential for non-contact monitoring for sepsis, the quick and costly killer

17th Jan 2020

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

  • AI & Analytics
  • Connectivity & IoT
  • Digital health
  • Sensing
  • Signal processing
Whitepaper

The future of patient monitoring

1st Jul 2019

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

  • AI & Analytics
  • Connectivity & IoT
  • Digital health
  • Digital security
  • Digital services
  • Human factors
  • Product realisation
  • Sensing
  • Service design
  • User Experience (UX)
Opinion

What’s next for targeted medicine? We report back from SLAS 2021

4th Feb 2021

Symon Cotton, Head of Life Sciences at Cambridge Consultants, attended this year’s Society for Laboratory Automation and Screening conference, SLAS2021. Even in virtual form, the speakers dazzled with fresh and exciting ideas for the future of patient treatments.

  • Bioinnovation
  • Digital health
Opinion

CellPreserve: our innovation could help prolong the lives of cancer patients

4th Feb 2021

Diagnosing cancer early to treat it more effectively is vital. Here, Josh Gibson, senior physicist at Cambridge Consultants, unveils a potentially life-saving breakthrough in the field of liquid biopsy that’s been hailed by a leading innovation award jury…

  • Bioinnovation
  • Digital health
Opinion

System architecture – your vital blueprint for success as a surgical start-up

4th Feb 2021

Now you’ve got a talented team together, surely it’s time to push on to design and build your device? Not quite. In the latest in his series of articles, our VP Surgical Robotics & Advanced Surgical Systems Andrew Savarese explains the crucial importance of system architecture, the vital blueprint for project efficiency… 

  • Digital health
  • Human factors
  • Physical sciences
Opinion

Our core technology is at the heart of the world’s first FDA-approved fully at-home COVID-19 test

22nd Jan 2021

The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.

  • Bioinnovation
  • Digital health
  • Fluids & thermodynamics
  • Sensing
Opinion

UK Human Tissue Authority licence enhances our next-generation therapy development

17th Dec 2020

We are delighted to report a significant step forward as we grow our bioinnovation capability as we have received our licence from the UK Human Tissue Authority to store human tissue for research purposes. This opens the way to future development in cell therapies and regenerative medicine. 

  • Bioinnovation
Opinion

De-risking growth for surgical start-ups

8th Dec 2020

After a tough year, C-suite executives of robotic start-ups are impatient for rapid progress. Andrew Savarese, VP Surgical Robotics & Advanced Surgical Systems, advocates a strategic, determined, thoughtful approach. Ultimately, he says, the team you assemble will determine your success…

  • Digital health
  • Human factors
  • Physical sciences
Opinion

Neuropathy screening from diabetic retinopathy images – a deep learning breakthrough

7th Dec 2020

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

  • AI & Analytics
  • Digital health
Opinion

Could a radical approach to mass screening conquer COVID this winter?

27th Nov 2020

The next step in the fight against coronavirus looks set to be mass screening of whole cities and towns. Symon Cotton, Head of Life Sciences at Cambridge Consultants, believes that so-called multipool screening could make all the difference to the success of this approach during the current second wave of the virus.

  • Dispense
Opinion

Mixing it up – a possible way to provide COVID-19 testing for all

26th Oct 2020

Symon Cotton explores the use of pooled testing techniques for deploying mass Covid testing.  

  • Bioinnovation
Opinion

Shooting for the moon: how to test 10 million samples for COVID-19

23rd Oct 2020

In September the UK government announced Operation Moonshot – to deliver the mass screening of 10 million samples for COVID-19 every day. Andrew Goulter takes a pragmatic look at five key areas of focus if we are to increase screening efficiency and capacity. 

  • Dispense